Semaglutide is a medication used to treat type 2 diabetes and for chronic weight management. It works by mimicking the hormone GLP-1, which helps to regulate blood sugar levels and appetite.
Tirzepatide is a dual GIP and GLP-1 receptor agonist, meaning it acts on two different receptors to help manage blood sugar levels in type 2 diabetes. This dual action can provide additional benefits over GLP-1 agonists alone.
Common side effects include nausea, vomiting, diarrhea, constipation, abdominal pain, and decreased appetite. These side effects often decrease over time.
Similar to Semaglutide, common side effects include nausea, vomiting, diarrhea, decreased appetite, and fatigue. These effects are usually most prominent when starting the medication.
Yes, both medications can cause serious side effects such as pancreatitis, kidney problems, gallbladder disease, and allergic reactions. Tirzepatide may also increase the risk of hypoglycemia when combined with other diabetes medications and has been associated with thyroid tumors in animal studies.
The duration of treatment depends on your individual health needs and response to the medication. These medications are often used long-term to manage type 2 diabetes or weight. Always follow your healthcare provider's advice regarding the duration of treatment.
Yes, Semaglutide (under the brand name Wegovy) is specifically approved for chronic weight management. Tirzepatide is also being studied for weight loss benefits, although its primary use is for diabetes management.
Both Semaglutide and Tirzepatide are typically administered via subcutaneous injection. Your healthcare provider will give you instructions on how to properly administer these injections.
If you miss a dose of Semaglutide or Tirzepatide, take it as soon as you remember. If it is close to your next scheduled dose, skip the missed dose and continue with your regular schedule. Do not take two doses at once. Contact your healthcare provider for specific guidance.
Yes, but it’s important to manage the potential risk of hypoglycemia. Always consult with your healthcare provider before combining medications to ensure safe and effective treatment.
These medications are not suitable for everyone. People with a history of pancreatitis, severe kidney problems, or a family history of medullary thyroid carcinoma should avoid these medications. Always discuss your medical history with your healthcare provider before starting any new treatment.
At Braxton Medical Clinic, LLC, we are dedicated to providing you with the best care and information. If you have any questions or concerns about Semaglutide (Wegovy/Ozempic) or Tirzepatide (Zepbound/Mounjaro), please contact us at 615-900-1659. We are here to support you on your journey to better health.